Skip to main content

Actavis Inc

No ongoing recalls currently shown

Based on the official records currently available to Public Health Trace, no recalls naming Actavis Inc are currently shown as ongoing. The 17 records below are historical recall records.

Public Health Trace has 17 recalls naming Actavis Inc as the recalling firm, republished from official FDA and USDA sources.

Recall history - 17 terminated records

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20131
20146
20153
20164
20173
Download CSV

FDA Recall TerminatedTerminated: February 23, 2015Historical recordClass II

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

by Actavis Inc

Reason
Subpotent Drug.
Published
June 25, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 4, 2014Historical recordClass II

Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 07962, Mfd. by: Debio RP, CH-1920 Martigny, Switzerland.

by Actavis Inc

Reason
Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.
Published
February 19, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 26, 2015Historical recordClass II

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75mg/0.2mg, Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60 (60 count bottles)

by Actavis Inc

Reason
Failed Tablet/Capsule Specifications: Broken tablets
Published
February 12, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2015Historical recordClass III

BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880

by Actavis Inc

Reason
Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.
Published
February 5, 2014
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 9, 2014Historical recordClass III

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.

by Actavis Inc

Reason
Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.
Published
August 14, 2013
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Actavis Inc as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.